Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.
IPO Year: 2000
Exchange: NASDAQ
Website: axcelis.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/20/2026 | $150.00 | Neutral → Buy | B. Riley Securities |
| 10/13/2025 | $90.00 | Neutral → Underperform | BofA Securities |
| 10/2/2025 | $105.00 | Hold → Buy | The Benchmark Company |
| 4/21/2025 | $50.00 | Buy → Neutral | B. Riley Securities |
| 2/12/2025 | Outperform → Mkt Perform | William Blair | |
| 11/8/2024 | Buy → Hold | The Benchmark Company | |
| 5/3/2024 | $130.00 | Hold → Buy | Craig Hallum |
| 12/15/2023 | Buy → Neutral | BofA Securities | |
| 9/15/2023 | $225.00 | Buy | BofA Securities |
| 8/4/2023 | $140.00 → $175.00 | Buy → Hold | Craig Hallum |
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
SD - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
10-Q - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
SCHEDULE 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
144 - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
SCHEDULE 13G - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
425 - AXCELIS TECHNOLOGIES INC (0001113232) (Filed by)
DEF 14A - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
SCHEDULE 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
Fastest customizable press release news feed in the world
BEVERLY, Mass., May 12, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences: The J.P. Morgan 2026 Global Technology, Media and Communications Conference on May 18th at the Westin Boston Seaport District.The 26th Annual B. Riley Investor Conference on Wednesday, May 20th at the Ritz-Carlton, Marina del Rey, CA. The Stifel 9th Annual Cross Sector Conference on Tuesday, June 2nd at the Inter
Q1 2026 Highlights:Revenue of $199.0 millionGAAP Gross Margin of 40.5%, and Non-GAAP Gross Margin of 40.7%GAAP Operating Margin of 4.0% and Non-GAAP Operating Margin of 11.7%GAAP Diluted Earnings Per Share of $0.30, and Non-GAAP Diluted Earnings Per Share of $0.72 BEVERLY, Mass., May 7, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the first quarter ended March 31, 2026. President and CEO Russell Low commented, "We executed well in the first quarter, delivering results slightly above expectations, reflecting the strength of o
BEVERLY, Mass., May 6, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today it will participate in the Advanced Semiconductor Manufacturing Conference (ASMC) taking place May 11 - 14, 2026, at the Hilton Albany in Albany, New York. ASMC brings together manufacturers, equipment and materials suppliers, and academia to solve manufacturing challenges with innovative strategies and methodologies. Axcelis technologists and collaborators will present during the technica
BEVERLY, Mass., April 23, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the first quarter of 2026 after market close on Thursday, May 7, 2026. The Company will host a call to discuss the results for the first quarter of 2026 on Thursday, May 7, 2026, at 5:00 p.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here: https://
BEVERLY, Mass., March 30, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, is pleased to announce the approval of its greenhouse gas (GHG) emissions reduction targets by the Science Based Targets initiative (SBTi). The SBTi is a corporate climate action organization that enables companies worldwide to play their part in combating the climate crisis. Axcelis has committed to achieve net-zero GHG emissions across the value chain by 2050. The company has been granted approval fro
President and CEO Russell Low will Present Keynote Speech at CS AsiaBEVERLY, Mass., March 19, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will be the Diamond Sponsor for the Compound Semiconductor Asia Conference (CS Asia) 2026, held in conjunction with SEMICON China 2026 on March 24-27, 2026, at the Kerry Hotel in Pudong, Shanghai. Axcelis' President and CEO, Russell Low, PhD, will present an opening Keynote Speech at the event. Hongchen Zhao, PhD
Hexcel Corporation (NYSE:HXL) announced today that James (Jamie) Coogan has been appointed Executive Vice President and Chief Financial Officer effective May 1, 2026. He will report to Tom Gentile, Hexcel Chairman, CEO and President. Coogan succeeds Mike Lenz who has been serving as interim Chief Financial Officer. Lenz will remain for a period of time when Coogan joins the company as a Senior Advisor to assist with the transition. "Jamie brings the experience and the financial leadership that will help Hexcel build on our momentum as we enter a period of growth with rising commercial aircraft production rates and an expanding defense and space market," said Tom Gentile, Chairman, CEO and
David Ryzhik Appointed Interim Chief Financial OfficerBEVERLY, Mass., March 12, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced that David Ryzhik, Senior Vice President of Investor Relations and Corporate Strategy, has been appointed Interim Chief Financial Officer, effective March 12. James Coogan is leaving the Company to pursue a CFO opportunity at a public company in a different industry and will remain with the Company through April 24 to ensure a smooth transition. Axcelis will initiate a search process with the assistance of a leading executive search firm to identify its next CFO.
BEVERLY, Mass., Feb. 23, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today the company's plans to participate in the following upcoming investor conferences: The Susquehanna Financial Group Fifteenth Annual Technology Conference, taking place at the Lotte New York Palace Hotel on February 26th and virtually on February 27th, 2026. Axcelis management will host one-on-one and small group meetings on Thursday, February 26th with interested investors. For more infor
Q4 Highlights:Revenue of $238 millionGAAP Gross Margin of 47.0%, and Non-GAAP Gross Margin of 47.3%GAAP Operating Margin of 15.2% and Non-GAAP Operating Margin of 21.1%GAAP Diluted Earnings Per Share of $1.10, and Non-GAAP Diluted Earnings Per Share of $1.49BEVERLY, Mass., Feb. 17, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2025. President and CEO Russell Low commented, "Axcelis exited 2025 on a strong note with fourth quarter results that exceeded our outlook. We achieve
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
B. Riley Securities upgraded Axcelis Tech from Neutral to Buy and set a new price target of $150.00
BofA Securities downgraded Axcelis Tech from Neutral to Underperform and set a new price target of $90.00
The Benchmark Company upgraded Axcelis Tech from Hold to Buy and set a new price target of $105.00
B. Riley Securities downgraded Axcelis Tech from Buy to Neutral and set a new price target of $50.00
William Blair downgraded Axcelis Tech from Outperform to Mkt Perform
The Benchmark Company downgraded Axcelis Tech from Buy to Hold
Craig Hallum upgraded Axcelis Tech from Hold to Buy and set a new price target of $130.00
BofA Securities downgraded Axcelis Tech from Buy to Neutral
BofA Securities initiated coverage of Axcelis Tech with a rating of Buy and set a new price target of $225.00
Craig Hallum downgraded Axcelis Tech from Buy to Hold and set a new price target of $175.00 from $140.00 previously
Live Leadership Updates
The Company Announces Planned Retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy BEVERLY, Mass., June 27, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today named David Ryzhik as Senior Vice President of Investor Relations and Corporate Strategy, assuming responsibility for the role in July 2024. The Company also announced the retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy. Mr. Lawson plans to retire in July 2024 and will remain as a Senior Advisor through July 2025.
BEVERLY, Mass., April 2, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today a shipment of the Company's Purion EXE™ SiC high energy implanter as well as a successful Purion H200™ SiC medium energy implanter evaluation closure at leading power device chipmakers located in Japan. The systems will be used for 150mm and 200mm production of silicon carbide power devices supporting automotive, industrial, energy, and other power intensive applications. Greg Redinbo,
SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company's Board of Directors effective immediately. Ms. Fallon will also become a member of the Company's Audit Committee. Ms. Fallon is the Executive Vice President, HR/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (NASDAQ:ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position sin
BEVERLY, Mass., Jan. 12, 2021 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today provided updated financial guidance for the fourth quarter of 2020. The Company expects revenue for the fourth quarter of 2020 to be approximately $120 million, above the $110 million prior guidance. Gross margin of approximately 43% is up from the previous gross margin guidance of 41%. As a result, the Company expects earnings per diluted share of approximately $0.32, up from the previous guidance of approximately $0.21. Cash will be greater than $200 million. Strong performance by our CS&I business contr
This live feed shows all institutional transactions in real time.
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
Live finance-specific insights
Q1 2026 Highlights:Revenue of $199.0 millionGAAP Gross Margin of 40.5%, and Non-GAAP Gross Margin of 40.7%GAAP Operating Margin of 4.0% and Non-GAAP Operating Margin of 11.7%GAAP Diluted Earnings Per Share of $0.30, and Non-GAAP Diluted Earnings Per Share of $0.72 BEVERLY, Mass., May 7, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the first quarter ended March 31, 2026. President and CEO Russell Low commented, "We executed well in the first quarter, delivering results slightly above expectations, reflecting the strength of o
BEVERLY, Mass., April 23, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the first quarter of 2026 after market close on Thursday, May 7, 2026. The Company will host a call to discuss the results for the first quarter of 2026 on Thursday, May 7, 2026, at 5:00 p.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here: https://
Q4 Highlights:Revenue of $238 millionGAAP Gross Margin of 47.0%, and Non-GAAP Gross Margin of 47.3%GAAP Operating Margin of 15.2% and Non-GAAP Operating Margin of 21.1%GAAP Diluted Earnings Per Share of $1.10, and Non-GAAP Diluted Earnings Per Share of $1.49BEVERLY, Mass., Feb. 17, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2025. President and CEO Russell Low commented, "Axcelis exited 2025 on a strong note with fourth quarter results that exceeded our outlook. We achieve
BEVERLY, Mass., Jan. 26, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the fourth quarter and full year 2025 after market close on Tuesday, February 17, 2026. The Company will host a call to discuss the results for the fourth quarter and full year 2025 on Tuesday, February 17, 2026, at 5:00 p.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by register
Q3 Highlights: Revenue of $213.6 millionGAAP Gross Margin of 41.6%, and Non-GAAP Gross Margin of 41.8%GAAP Operating Margin of 11.7% and Non-GAAP Operating Margin of 18.2%GAAP Diluted earnings per share of $0.83, and Non-GAAP Diluted earnings per share of $1.21BEVERLY, Mass., Nov. 4, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the third quarter ended September 30, 2025. President and CEO Russell Low commented, "We delivered another solid quarter, with sales and earnings both exceeding our expectations. We are also pleased
BEVERLY, Mass., Oct. 22, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the third quarter 2025 before the opening of the market on Tuesday, November 4, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here:https://register-conf.media-server.c
Diversifies Portfolio with Complementary Capital Equipment Solutions and Expands Addressable Markets Supported by Secular Tailwinds Greater R&D Scale to Fuel Differentiated, Next-Generation Technologies for Customers Resilient Pro-Forma Operating Profile and Balance Sheet to Support Investment in Organic Growth Initiatives and Share Repurchase Program Expected to be Accretive to Non-GAAP Earnings Per Share Within the First Year Post Closing Will Host Joint Conference Call and Webcast Today at 8:30 AM ET BEVERLY, Mass., and PLAINVIEW, N.Y., Oct. 1, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) and Veeco Instruments Inc. (NASDAQ:VECO) today announced that they have entered in
Q2 Highlights: Revenue of $194.5 millionGAAP Gross Margin of 44.9%, and Non-GAAP Gross Margin of 45.2%GAAP Operating Margin of 14.9% and Non-GAAP Operating Margin of 17.7%GAAP Diluted earnings per share of $0.98, and Non-GAAP Diluted earnings per share of $1.13BEVERLY, Mass., Aug. 5, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the second quarter ended June 30, 2025. President and CEO Russell Low commented, "Axcelis delivered strong results in the second quarter despite the cyclical digestion period in many of our markets,
BEVERLY, Mass., July 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the second quarter 2025 before the opening of the market on Tuesday, August 5, 2025. The Company will host a call the same day to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here:https://register-conf.media-server.co
Q1 Highlights: Revenue of $192.6 millionGAAP Gross Margin of 46.1%, and Non-GAAP Gross Margin of 46.4%GAAP Operating Margin of 15.1% and Non-GAAP Operating Margin of 18.3%GAAP Diluted earnings per share of $0.88, and Non-GAAP Diluted earnings per share of $1.04BEVERLY, Mass., May 6, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the first quarter ended March 31, 2025. President and CEO Russell Low commented, "We executed well in the first quarter, delivering strong profitability despite a moderation in customer investments a